Neglected Diseases

Neglected Diseases — Malaria Technologies Available from NIH, Universities and Other Non-profit Organizations JOHNS HOPKINS UNIVERSITY (JHU)
JHU 1361	2,3-Dioxabicyclo[3.3.1]Nonane Derivatives and Antimalarial Pharmaceutical Compositions Comprising Them
JHU 1320	Water-Soluble Trioxanes as Potent and Safe Antimalarial Agents
JHU 1176	Novel Continuous and Cross-Reacting Epitope for Human Malaria Vaccine
JHU 1158	1, 2, 4 - Trioxanes Having Antimalarial Activity
NATIONAL INSTITUTES OF HEALTH (NIH)
E-221-2004	Chondroitin Sulphate A Binding Domains: Potential Vaccine for Malaria
E-049-2004	Anti-Plasmodium Compositions and Methods of Use
E-176-2003	Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria
E-328-2000	Identification of New Malaria Parasite Erythrocyte Binding Protein (BAEBL) that Binds to Human Red Cells
E-203-1999	Identification of the Domain of Plasmodium falciparum Erythrocyte Membrane Protein (PfEMP1) that Mediates Adhesion to Chondroitin Sulfate A
E-019-1998	Vaccines for Blocking Transmission of Plasmodium vivax
E-202-1997	Methods for Treating Parasitic Infection Using Thiopeptides
E-221-1994	Peptidomimetic Inhibitors of Cathepsin D and Plasmepsins I and II
E-201-1994 E-200-1994 E-090-1994	Novel Antimalarial Compounds, Methods of Synthesis Thereof, Pharmaceutical Compositions Comprising Same, and Methods of Using Same for Treatment and Prevention of Malaria
E-096-1994	Antimalarial Korupensamines and Pharmaceutical Compositions and Medical Uses Thereof
E-133-1993	Binding Domains from Plasmodium vivax and Plasmodium falciparum Erythrocyte Binding Proteins
E-149-1992	Target Antigens of Transmission-Blocking Antibodies for Malaria Parasites
E-055-1991	Transmission-Blocking Vaccine Against Malaria
E-035-1991	Transmission-Blocking Vaccine Against Malaria
E-090-1990	Plasmodium vivax and Plasmodium knowlesi Duffy Receptor
E-226-1988	Synthetic Vaccine Against P. falciparum Malaria
E-122-1988	Gene for Encoding a Human Malaria Vaccine Antigen
E-167-1987	Malarial Immunogen
E-318-1986	Recombinant DNA Clone Containing a Genomic Fragment of PfHRP-II Gene from Plasmodium falciparum
* Some technologies have multiple potential uses.

	Overview
	African Trypanosomiasis (Sleeping Sickness)
	Dengue Fever
	General (Vaccines and Biotherapeutics)
	Hepatitis B
	HIV/AIDS
	Intestinal Parasites
	Leprosy
	Lymphatic Filariasis (Elephantiasis)
	Malaria
	Rotavirus
	Schistosomiasis
	Tuberculosis
	Visceral Leishmaniasis